KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Assets Average (2018 - 2025)

Historic Assets Average for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Q3 2025 value amounting to $3.5 billion.

  • Amneal Pharmaceuticals' Assets Average rose 74.25% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year increase of 74.25%. This contributed to the annual value of $3.5 billion for FY2024, which is 409.65% down from last year.
  • According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Assets Average is $3.5 billion, which was up 74.25% from $3.4 billion recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Assets Average registered a high of $4.0 billion during Q3 2021, and its lowest value of $3.4 billion during Q2 2025.
  • For the 5-year period, Amneal Pharmaceuticals' Assets Average averaged around $3.7 billion, with its median value being $3.7 billion (2023).
  • Its Assets Average has fluctuated over the past 5 years, first tumbled by 760.22% in 2023, then surged by 74.25% in 2025.
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' Assets Average stood at $4.0 billion in 2021, then dropped by 3.04% to $3.8 billion in 2022, then dropped by 6.69% to $3.6 billion in 2023, then decreased by 2.75% to $3.5 billion in 2024, then grew by 0.87% to $3.5 billion in 2025.
  • Its Assets Average stands at $3.5 billion for Q3 2025, versus $3.4 billion for Q2 2025 and $3.4 billion for Q1 2025.